The first medications to correct poor tissue oxygenation are a step closer, scientists in the USA have reported.
Treatments might help sickle cell disease as well as heart failure and peripheral artery disease, researchers said.
A team at Harringt...
1 year ago
Scientists have hailed ‘encouraging results’ for treatment of acute leukaemias that have KMT2A rearrangements or NPM1 mutations.
A phase 1 trial of the drug revumenib has showed, among 60 patients with advanced acute leukaemias with KMT2A rearrang...
1 year ago
